Order Article Reprints

Tampucci S, Monti D, Burgalassi S, Terreni E, Zucchetti E, Baldacci F, Chetoni P. Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment. Pharmaceutics. 2018; 10(3):137. https://doi.org/10.3390/pharmaceutics10030137

Tampucci, Silvia, Daniela Monti, Susi Burgalassi, Eleonora Terreni, Erica Zucchetti, Filippo Baldacci, and Patrizia Chetoni. 2018. "Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment" Pharmaceutics 10, no. 3: 137. https://doi.org/10.3390/pharmaceutics10030137

Tampucci, S., Monti, D., Burgalassi, S., Terreni, E., Zucchetti, E., Baldacci, F., & Chetoni, P. (2018). Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment. Pharmaceutics, 10(3), 137. https://doi.org/10.3390/pharmaceutics10030137